If you are ready to simplify and reduce the time it takes to connect with reporters for the research and innovation at your institution, we are here for you.
It’s almost time to don your outfit for the 31st, but keep in mind some important safety tips, say doctors at Philadelphia’s Wills Eye Hospital, that may keep you from doing real harm to your eyes -potentially landing yourself in the emergency room and in some cases, risking permanent vision loss.
Patients, families, friends and physicians pay tribute to the many contributions that have been made during the past 40 years by the Wills Eye Ocular Oncology Service and Drs. Jerry and Carol Shields.
Nearly 3000 new eye cancer cases occur each year in adults and children.
The team at Wills Eye Hospital has the most advanced treatment options and success rates for helping patients at any stage of the disease.
March 1, 2016 - today announced it has treated the first RESCUE trial patient in the United States enrolled in an FDA-approved gene therapy vision research study. This represents a significant new chapter in the potentially wider use of gene therapy for treating, curing or even reversing certain cases of vision loss. The hope for the 50 year old patient, who has a vision-threatening genetic disease called Leber’s Hereditary Optic Neuropathy (LHON) is that his eye-injection will correct the defective gene that is causing his severe vision loss and either stops the progression of the disease or reverses the damage and improves his sight.
These are medications that many patients with eye conditions use every day, and it can be frustrating to run out of your drops early or have trouble getting your drops in. So we're going to try and give you some tips to help out with that.
Diabetes is expected to impact 50% of all Americans by the year 2050. What's even more troubling is that according to the American Diabetes Association, 86 million Americans are pre-diabetic -- with 77 million of them not even realizing they are at risk for having the disease. In many cases, patients first learn of having the disease after experiencing acute vision symptoms. Here's how Wills Eye is making major strides in tackling this epidemic.
A first-of-its-kind, potentially groundbreaking new option for treating a form of eye cancer is now in its first phase-1 clinical research trial at Wills Eye Hospital in Philadelphia.